AAAAAA

   
Results: 1-9 |
Results: 9
A survey of the current clinical facilities for the management of familialcancer in Europe
Authors: Hodgson, SV Haites, NE Caligo, M Chang-Claude, J Eccles, D Evans, G Moller, P Morrison, P Steel, CM Stoppa-Lyonnet, D Vasen, H
Citation: Sv. Hodgson et al., A survey of the current clinical facilities for the management of familialcancer in Europe, J MED GENET, 37(8), 2000, pp. 605-607
The exon 13 duplication in the BRCA1 gene is a founder mutation present ingeographically diverse populations
Authors: Mazoyer, S Leary, J Kirk, J Fleischmann, E Wagner, T Claes, K Messiaen, L Foulkes, W Desrochers, M Simard, J Phelan, CM Kwan, E Narod, SA Vahteristo, P Nevanlinna, H Durando, X Bignon, YJ Peyrat, JP Bonnardel, C Sinilnikova, OM Puget, N Lenoir, GM Mazoyer, S Audoynaud, C Goldgar, D Maugard, C Caux, V Gad, S Stoppa-Lyonnet, D Nogues, C Lidereau, R Machavoine, C Bressac-de Paillerets, B Kuschel, B Betz, B Niederacher, D Beckmann, MW Hamann, U Gayther, SA Ponder, BAP Robinson, M Taylor, GR Bishop, T Catteau, A Solomon, E Cohen, B Steel, M Collins, N Stratton, M van der Looij, M Olah, E Miller, NJ Barton, DE Sverdlov, RS Friedman, E Radice, P Montagna, M Sensi, E Caligo, M van Eijk, R Devilee, P van der Luijt, R Heimdal, K Moller, P Borg, A Diez, O Cortes, J Domenech, M Baiget, M Osorio, A Benitez, J Borg, A Maillet, P Sappino, AP Ozdag, H Ozcelik, T Ozturk, M Rohlfs, EM Boyd, J McDermott, D Offit, K Unger, M Nathanson, K Weber, BL Sellers, TA Hampton, E Couch, FJ Neuhausen, S
Citation: S. Mazoyer et al., The exon 13 duplication in the BRCA1 gene is a founder mutation present ingeographically diverse populations, AM J HU GEN, 67(1), 2000, pp. 207-212
Current policies for surveillance and management in women at risk for breast and ovarian cancer: A survey among 16 European family cancer clinics
Authors: Vasen, HFA Haites, NE Evans, DGR Steel, CM Moller, P Hodgson, S Eccles, D Morrison, P Stoppa-Lyonnet, D Chang-Claude, J Caligo, M
Citation: Hfa. Vasen et al., Current policies for surveillance and management in women at risk for breast and ovarian cancer: A survey among 16 European family cancer clinics, DIS MARKER, 15(1-3), 1999, pp. 47-47
Risk estimation as a decision-making tool for genetic analysis of the breast cancer susceptibility genes
Authors: Chang-Claude, J Becher, H Caligo, M Eccles, D Evans, G Haites, N Hodgson, S Moller, P Weber, BHF Stoppa-Lyonnet, D
Citation: J. Chang-claude et al., Risk estimation as a decision-making tool for genetic analysis of the breast cancer susceptibility genes, DIS MARKER, 15(1-3), 1999, pp. 53-65
Genetic testing for breast cancer predisposition in 1999: which molecular strategy and which family criteria?
Authors: Stoppa-Lyonnet, D Caligo, M Eccles, D Evans, DGR Haites, NE Hodgson, NS Moller, P Morrison, PJ Steel, CM Vasen, HFA Chang-Claude, J
Citation: D. Stoppa-lyonnet et al., Genetic testing for breast cancer predisposition in 1999: which molecular strategy and which family criteria?, DIS MARKER, 15(1-3), 1999, pp. 67-68
Ethical, social and economic issues in familial breast cancer: a compilation of views from the EC biomed II demonstration project
Authors: Steel, M Smyth, E Vasen, H Eccles, D Evans, G Moller, P Hodgson, S Stoppa-Lyonnet, D Chang-Claude, J Caligo, M Morrison, P Haites, N
Citation: M. Steel et al., Ethical, social and economic issues in familial breast cancer: a compilation of views from the EC biomed II demonstration project, DIS MARKER, 15(1-3), 1999, pp. 125-131
Insurance implications for individuals with a high risk of breast and ovarian cancer in Europe
Authors: Morrison, PJ Steel, CM Vasen, HFA Eccles, D Evans, DGR Moller, P Hodgson, S Stoppa-Lyonnet, D Chang-Claude, J Caligo, M Olah, E Haites, NE Nevin, NC
Citation: Pj. Morrison et al., Insurance implications for individuals with a high risk of breast and ovarian cancer in Europe, DIS MARKER, 15(1-3), 1999, pp. 159-165
Guidelines for follow-up of women at high risk for inherited breast cancer: Consensus statement from the Biomed 2 Demonstration Programme on Inherited Breast Cancer
Authors: Moller, P Evans, G Haites, N Vasen, H Reis, MM Anderson, E Apold, J Hodgson, S Eccles, D Olsson, H Stoppa-Lyonnet, D Chang-Claude, J Morrison, PJ Bevilacqua, G Heimdal, K Maehle, L Lalloo, F Gregory, H Preece, P Borg, A Nevin, NC Caligo, M Steel, CM
Citation: P. Moller et al., Guidelines for follow-up of women at high risk for inherited breast cancer: Consensus statement from the Biomed 2 Demonstration Programme on Inherited Breast Cancer, DIS MARKER, 15(1-3), 1999, pp. 207-211
Current policies for surveillance and management in women at risk of breast and ovarian cancer: A survey among 16 European family cancer clinics
Authors: Vasen, HFA Haites, NE Evans, DGR Steel, CM Moller, P Hodgson, S Eccles, D Morrison, P Lyonet, DS Chang-Claude, J Caligo, M
Citation: Hfa. Vasen et al., Current policies for surveillance and management in women at risk of breast and ovarian cancer: A survey among 16 European family cancer clinics, EUR J CANC, 34(12), 1998, pp. 1922-1926
Risultati: 1-9 |